Loew Caroline 4
4 · Mural Oncology plc · Filed Mar 4, 2024
Insider Transaction Report
Form 4
Loew Caroline
DirectorChief Executive Officer
Transactions
- Award
Ordinary Shares
2024-03-01+48,475→ 252,922 total - Award
Stock Option (right to buy)
2024-03-01+90,025→ 90,025 totalExercise: $5.39Exp: 2034-02-28→ Ordinary Shares (90,025 underlying)
Footnotes (2)
- [F1]Consists of ordinary shares issuable under 48,475 restricted stock units ("RSUs"). Each RSU represents the right to receive one ordinary share of the Issuer upon vesting. These RSUs are scheduled to vest with respect to 25% of the underlying ordinary shares on each of the first four anniversaries of March 1, 2024, subject to the reporting person's continued service with the Issuer.
- [F2]This option was granted on March 1, 2024. The option is scheduled to vest with respect to 25% of the underlying ordinary shares on March 1, 2025 and the remaining 75% of the underlying ordinary shares shall vest in 12 equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer.